Tamibarotene capsule preparation
US8252837B2 · kind B2 · utility
Assignee
Inventor
Key dates
| Filing date | Mar 28, 2008 |
| Grant date | Aug 28, 2012 |
| Priority date | — |
| Expiry date | Apr 8, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a practical preparation form of Tamibarotene and dosage form thereof, which exhibit high absorptivity by the body with minimized toxicity, and which are safe and stable without any risk of contamination. It is provided a Tamibarotene capsule preparation which encapsulates a composition comprising an oil component as its base and Tamibarotene as an active ingredient dissolved in the base. It is preferred that the oil component be propylene glycol fatty acid esters or polyethylene glycols. It is also preferred that the Tamibarotene capsule preparation comprise 0.1-50 mg/mL of the Tamibarotene based on the oil component.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.